Optic neuritis
Optic neuritis is inflammatory demyelination of the optic nerve, usually a presenting event of multiple sclerosis, causing subacute painful monocular vision loss with a relative afferent pupillary defect. Confirm with MRI orbits/brain and treat with IV methylprednisolone followed by an oral prednisone taper, never oral prednisone alone.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
Inflammatory demyelinating optic neuropathy: optic neuritis is inflammation of the optic nerve, most commonly autoimmune and associated with multiple sclerosis (MS), though it can occur as an…
- Epidemiology
Young women predominate: most patients are 20-40 years old and female, the demographic that predominates in MS; prevalence increases with distance from the equator, mirroring MS.
- Risk factors
Female sex and age 20-40 years, the core epidemiologic risk profile shared with MS.
- Pathophysiology
Autoimmune, T-cell-mediated demyelination: inflammatory infiltration of the optic nerve interrupts axonal conduction, the same process producing MS plaques elsewhere in the central nervous system.
- Clinical features
Subacute, painful, unilateral vision loss over hours to days is the hallmark and, with the exam findings below, establishes the clinical pattern; bilateral, painless, or minutes-to-onset…
- Differential diagnosis
Arteritic anterior ischemic optic neuropathy (giant cell arteritis): the most dangerous mimic, over age 50; jaw claudication, temporal artery tenderness, fever, and an elevated ESR/CRP with a pale…
- Diagnosis
Optic neuritis is a clinical diagnosis: subacute painful monocular vision loss with a relative afferent pupillary defect, decreased color vision, and a central/cecocentral scotoma establishes it; MRI…
- Management
First, exclude the arteritic mimic before treating: if the patient is over 50 or has jaw claudication, scalp tenderness, or an elevated ESR/CRP, manage as arteritic anterior ischemic optic neuropathy…
- Complications
Residual visual deficit: even with treatment, persistent reduction in acuity, color vision, or contrast sensitivity, with optic disc pallor (atrophy) weeks to months later.
- Prognosis
Most patients recover vision even without treatment, though IV methylprednisolone speeds recovery; residual color vision or contrast sensitivity deficit is common despite acuity recovery.
- Prevention
Risk-stratify every clinically isolated syndrome with brain MRI: lesions present carry an approximately 90% 10-year risk of converting to relapsing-remitting MS and warrant referral for…
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Multiple sclerosis
Multiple sclerosis is an autoimmune, demyelinating CNS disorder causing optic neuritis, myelitis, and brainstem/cerebellar syndromes separated in space and time. Diagnosis uses the McDonald MRI-based criteria; acute relapses are treated with high-dose glucocorticoids, and disease-modifying therapy (interferon beta, glatiramer, or a higher-efficacy agent such as ocrelizumab or natalizumab) is started early to prevent relapse and disability accumulation.
- Arteritic anterior ischemic optic neuropathy
Sudden painless monocular vision loss from occlusion of the posterior ciliary artery by giant cell arteritis infarcts the optic nerve head and threatens the fellow eye within days. Treatment with high-dose glucocorticoids must begin on clinical suspicion, before biopsy confirmation, because established blindness is usually permanent.
- Papilledema
Papilledema is bilateral optic disc swelling from raised intracranial pressure, most classically idiopathic intracranial hypertension; imaging to exclude a mass lesion or venous sinus thrombosis must precede lumbar puncture, and acetazolamide is the first-line drug once idiopathic intracranial hypertension is confirmed.
- Giant cell arteritis
Giant cell arteritis is a granulomatous large- and medium-vessel vasculitis of patients over 50 that threatens irreversible blindness through ischemic optic neuropathy. Diagnosis is clinical and must not delay treatment: start high-dose glucocorticoids immediately on suspicion, intravenous methylprednisolone pulse for visual loss, then confirm with temporal artery biopsy within 1 to 2 weeks and add tocilizumab as glucocorticoid-sparing therapy.
- Transverse myelitis
Transverse myelitis is inflammation across one or more contiguous spinal cord segments causing subacute weakness, a sensory level, and bladder or bowel dysfunction; diagnosis requires spinal MRI showing cord enhancement or CSF inflammation with exclusion of compressive and infectious causes, and idiopathic disease is treated with high-dose intravenous methylprednisolone.
- Idiopathic intracranial hypertension (pseudotumor cerebri)
Idiopathic intracranial hypertension (formerly pseudotumor cerebri) is raised intracranial pressure of unclear cause, without a mass lesion or hydrocephalus, occurring mainly in obese women of childbearing age and presenting with headache, papilledema, and visual symptoms. Diagnosis requires an elevated lumbar puncture opening pressure with normal CSF and normal or empty-sella imaging; treatment centers on weight loss and acetazolamide to protect vision, with surgery reserved for medically refractory disease.
- Central retinal artery occlusion
Central retinal artery occlusion is sudden, painless, profound monocular vision loss from embolic or thrombotic occlusion of the central retinal artery, an ocular stroke equivalent in which irreversible retinal infarction begins around 90 minutes after complete occlusion. Diagnosis is clinical on dilated fundoscopy, and management pairs time-critical reperfusion attempts with an emergency embolic and giant-cell-arteritis workup to protect the fellow eye and prevent a subsequent stroke.
- Acute angle-closure glaucoma
Acute angle-closure glaucoma is a pupillary-block emergency in which sudden closure of the iridocorneal angle blocks aqueous outflow, causing severe eye pain, halos, and rapidly rising intraocular pressure that can blind the eye within hours if not treated. Diagnosis is clinical plus tonometry and gonioscopy; treatment is immediate topical and systemic IOP-lowering therapy followed by laser peripheral iridotomy.
- Sarcoidosis
Sarcoidosis is a multisystem granulomatous disease of unknown cause defined by noncaseating granulomas, most commonly involving the lungs and hilar lymph nodes. Most patients are asymptomatic or have a self-limited course staged by chest radiograph; symptomatic organ-threatening disease is treated with systemic glucocorticoids, with methotrexate or another steroid-sparing agent added for glucocorticoid-refractory or glucocorticoid-intolerant disease.
- Lyme disease
Lyme disease is a tick-borne spirochetal infection caused by Borrelia burgdorferi that progresses from erythema migrans through early disseminated cardiac and neurologic disease to late arthritis, diagnosed clinically when erythema migrans is present and otherwise by two-tiered serology, and treated with staged doxycycline, amoxicillin, or cefuroxime regimens.